NCT00814515View on ClinicalTrials.gov

Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

482

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Moderate to Severe Dry Eye Syndrome

Interventions

DRUG

NOVA22007 (Ciclosporin 0.1%)

Ciclosporin 0.1% Ophthalmic Emulsions

DRUG

NOVA22007

Vehicle

Trial Locations (1)

75012

Hôpital des XV-XX, Paris

All Listed Sponsors

lead

Santen SAS

INDUSTRY

NCT00814515 - Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome | Biotech Hunter | Biotech Hunter